Article
Attenuation of TGF-β signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model.
Cancer letters - 28 Apr 2014
Biswas Tanuka, Gu Xiang, Yang Junhua, Ellies Lesley G, Sun Lu-Zhe
Abstract excerpt
Previous studies have suggested that TGF-β functions as a tumor promoter in metastatic, mesenchymal-like breast cancer cells and that TGF-β inhibitors can effectively abrogate tumor progression in several of these models. Here we report a novel observation with the use of genetic and pharmacological approaches, and murine mammary cell injection models in both syngeneic and immune compromised mice. We found that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
